Allogene Therapeutics, Inc.
USD2.22
+0.09 (+4.23%)
CEO
David D. Chang
IPO Date
2018-10-11
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.15
Prev. Close
$2.13
Day Low
$2.13
Day High
$2.24
52W Low
$0.98
52W High
$4.46
Market Cap
$0.54B
Volume
14.64M
| -1.6 |
| 31 Dec 2023 | FY | 100.0% | -344489.5% | -63.9% | -50.9% | 0.19 | 12.38 | -1.5 |
| 31 Dec 2022 | FY | -9063.5% | -218214.1% | -51.0% | -41.4% | 0.15 | 9.84 | -2.6 |
| 31 Dec 2021 | FY | 100.0% | -159.6% | -19.7% | -17.3% | 0.08 | 9.84 | -11.1 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -23.2% | -20.4% | 0.05 | 8.96 | -12.1 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -29.3% | -25.7% | 0.08 | 16.46 | -14.2 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -30.1% | -27.3% | 0.05 | 15.89 | -11.4 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | 100.0% | 0.0% | 0.00 | 0.00 | -550140.9 |
| -1.9 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -13.1% | -9.4% | 0.27 | 8.19 | -1.7 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -14.8% | -10.8% | 0.23 | 8.92 | -1.2 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -15.5% | -11.8% | 0.21 | 9.71 | -1.3 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -14.2% | -10.9% | 0.21 | 8.54 | -1.9 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -14.3% | -11.3% | 0.18 | 9.35 | -2.2 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -12.9% | -10.3% | 0.18 | 12.25 | -1.7 |
| 31 Mar 2024 | Q1 | -16059.1% | -295454.5% | -14.1% | -11.1% | 0.21 | 12.80 | -2.8 |
| 31 Dec 2023 | Q4 | 100.0% | 202856.8% | -17.4% | -13.9% | 0.19 | 12.38 | -1.5 |